Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study-Reference-Cited by-同舟云学术

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Published:2008-11 Issue:11 Volume:58 Page:3319-3329
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Keystone Edward,Heijde Désireé Van Der,Mason David,Landewé Robert,Vollenhoven Ronald Van,Combe Bernard,Emery Paul,Strand Vibeke,Mease Philip,Desai Chintu,Pavelka Karel

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference19 articles.

1. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial;Moreland;Ann Intern Med,1999

2. Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial;Weinblatt;Arthritis Rheum,2003

3. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate;Maini;Arthritis Rheum,2004

4. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes;Genovese;Arthritis Rheum,2002

5. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial;Keystone;Arthritis Rheum,2004

Cited by 496 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis;Rheumatology;2024-09-02

2. Indigenous Medicinal Plants Based Remedies in Management of Arthritis by <i>Irula</i> Tribals of Tamil Nadu – A Comprehensive Review;Journal of Natural Remedies;2024-07-31

3. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

4. Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis;JAMA Network Open;2024-06-26

5. Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study;Modern Rheumatology;2024-03-29